233 related articles for article (PubMed ID: 33246937)
41. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
Kouchaki B; Janbabai G; Alipour A; Ala S; Borhani S; Salehifar E
Support Care Cancer; 2018 Jul; 26(7):2479-2489. PubMed ID: 29442239
[TBL] [Abstract][Full Text] [Related]
42. Report of a pilot, double-blind, placebo-controlled study of megestrol acetate in elderly dialysis patients with cachexia.
Yeh SS; Marandi M; Thode HC; Levine DM; Parker T; Dixon T; Schuster MW
J Ren Nutr; 2010 Jan; 20(1):52-62. PubMed ID: 19819724
[TBL] [Abstract][Full Text] [Related]
43. A Systematic Review and Meta-Analysis of the Clinical Use of Megestrol Acetate for Cancer-Related Anorexia/Cachexia.
Lim YL; Teoh SE; Yaow CYL; Lin DJ; Masuda Y; Han MX; Yeo WS; Ng QX
J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807039
[TBL] [Abstract][Full Text] [Related]
44. Pharmacological treatment of cachexia: any progress?
Bruera E
Support Care Cancer; 1998 Mar; 6(2):109-13. PubMed ID: 9540168
[TBL] [Abstract][Full Text] [Related]
45. [Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].
Mücke M; Carter C; Cuhls H; Prüß M; Radbruch L; Häuser W
Schmerz; 2016 Feb; 30(1):25-36. PubMed ID: 26809975
[TBL] [Abstract][Full Text] [Related]
46. [Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss].
Herrejón A; Palop J; Inchaurraga I; López A; Bañuls C; Hernández A; Blanquer R; Están N; Anguera A
Med Clin (Barc); 2011 Jul; 137(5):193-8. PubMed ID: 21524765
[TBL] [Abstract][Full Text] [Related]
47. The efficacy and safety of anamorelin for patients with cancer-related anorexia/cachexia syndrome: a systematic review and meta-analysis.
Taniguchi J; Mikura S; da Silva Lopes K
Sci Rep; 2023 Sep; 13(1):15257. PubMed ID: 37709824
[TBL] [Abstract][Full Text] [Related]
48. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Crit Rev Oncog; 1998; 9(2):99-106. PubMed ID: 9973244
[TBL] [Abstract][Full Text] [Related]
49. Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial.
De Conno F; Martini C; Zecca E; Balzarini A; Venturino P; Groff L; Caraceni A
Eur J Cancer; 1998 Oct; 34(11):1705-9. PubMed ID: 9893656
[TBL] [Abstract][Full Text] [Related]
50. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
Jatoi A; Windschitl HE; Loprinzi CL; Sloan JA; Dakhil SR; Mailliard JA; Pundaleeka S; Kardinal CG; Fitch TR; Krook JE; Novotny PJ; Christensen B
J Clin Oncol; 2002 Jan; 20(2):567-73. PubMed ID: 11786587
[TBL] [Abstract][Full Text] [Related]
51. Treatment of anorexia with megestrol acetate.
Tchekmedyian NS
Nutr Clin Pract; 1993 Jun; 8(3):115-8. PubMed ID: 8289758
[TBL] [Abstract][Full Text] [Related]
52. Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy.
Greig CA; Johns N; Gray C; MacDonald A; Stephens NA; Skipworth RJ; Fallon M; Wall L; Fox GM; Fearon KC
Support Care Cancer; 2014 May; 22(5):1269-75. PubMed ID: 24389826
[TBL] [Abstract][Full Text] [Related]
53. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.
Mantovani G; Macciò A; Madeddu C; Serpe R; Massa E; Dessì M; Panzone F; Contu P
Oncologist; 2010; 15(2):200-11. PubMed ID: 20156909
[TBL] [Abstract][Full Text] [Related]
54. Treating malnutrition with megestrol acetate: literature review and review of our experience.
Karcic E; Philpot C; Morley JE
J Nutr Health Aging; 2002 May; 6(3):191-200. PubMed ID: 12152625
[TBL] [Abstract][Full Text] [Related]
55. Studies of high-dose megestrol acetate: potential applications in cachexia.
Aisner J; Tchekmedyian NS; Tait N; Parnes H; Novak M
Semin Oncol; 1988 Apr; 15(2 Suppl 1):68-75. PubMed ID: 3285486
[TBL] [Abstract][Full Text] [Related]
56. Appetite stimulation and weight gain with megestrol acetate.
Aisner J; Parnes H; Tait N; Hickman M; Forrest A; Greco FA; Tchekmedyian NS
Semin Oncol; 1990 Dec; 17(6 Suppl 9):2-7. PubMed ID: 2259925
[TBL] [Abstract][Full Text] [Related]
57. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
[TBL] [Abstract][Full Text] [Related]
58. [Usefulness of megestrol acetate for weight gain in neoplastic patients with cachexia].
Tuca A
Med Clin (Barc); 2003 May; 120(17):678; author reply 678. PubMed ID: 12747821
[No Abstract] [Full Text] [Related]
59. Toward a treatment for anorexia and cachexia in patients with cancer.
Thirlby RC
Gastroenterology; 1991 Jul; 101(1):268-70. PubMed ID: 2044918
[No Abstract] [Full Text] [Related]
60. [Standards, Options and Recommendations (SOR) for the use of appetite stimulants in oncology. Work group. Federation of the French Cancer Centres (FNCLCC)].
Desport JC; Blanc-Vincent MP; Gory-Delabaere G; Bachmann P; Béal J; Benamouzig R; Colomb V; Kere D; Melchior JC; Nitenberg G; Raynard B; Scheiner S; Senesse P
Bull Cancer; 2000 Apr; 87(4):315-28. PubMed ID: 10827350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
